COR
Cencora, Inc.
NYSE · USHealthcareMedical - Distribution
$303.99-1.27%
Price as of Jul 20, 2026
COR growth
Cencora, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +5.9%
- EBITDA
- +34.8%
- EBIT
- +32.0%
- EPS
- +51.2%
- Free cash flow
- -56.4%
- Operating cash flow
- -44.6%
Forward estimates
- Revenue
- +10.6%
- EBITDA
- -8.7%
- EPS
- +45.1%
Three-year CAGR
- Revenue
- +10.4%
- EBITDA
- +6.3%
- EBIT
- +9.9%
- Net income
- -2.9%
- EPS
- -0.5%
- Free cash flow
- +13.3%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.